Globus Medical Inc
NYSE:GMED
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
49.79
85.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Globus Medical Inc
Operating Margin
Globus Medical Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | US |
| Market Cap | 11.3B USD |
| Operating Margin |
7%
|
| Country | US |
| Market Cap | 199B USD |
| Operating Margin |
17%
|
| Country | US |
| Market Cap | 191.3B USD |
| Operating Margin |
26%
|
| Country | US |
| Market Cap | 141.3B USD |
| Operating Margin |
22%
|
| Country | US |
| Market Cap | 134.2B USD |
| Operating Margin |
18%
|
| Country | IE |
| Market Cap | 104.6B USD |
| Operating Margin |
19%
|
| Country | US |
| Market Cap | 65.6B USD |
| Operating Margin |
14%
|
| Country | DE |
| Market Cap | 58.1B EUR |
| Operating Margin |
12%
|
| Country | US |
| Market Cap | 44.5B USD |
| Operating Margin |
28%
|
| Country | CN |
| Market Cap | 307.8B CNY |
| Operating Margin |
36%
|
| Country | US |
| Market Cap | 36.3B USD |
| Operating Margin |
13%
|
Globus Medical Inc
Glance View
Globus Medical Inc., founded in 2003, has crafted a distinctive narrative in the landscape of medical technology, rooted in innovation and practicality. Emerging from a profound understanding of spinal pathologies, the company has steadily risen to become a pivotal player in the musculoskeletal sector. Its journey is steered by a commitment to addressing complex spine disorders through the development of cutting-edge products that are not only innovative but also substantially user-friendly for both surgeons and patients. This fusion of technology and practicality is what sets Globus Medical apart. The company relentlessly focuses on expanding its product offerings through significant investments in research and development, continuously pushing the envelope in areas such as minimally invasive surgery, advanced surgical approaches, and imaging, which form the core of its business operations. The heart of Globus Medical's revenue model lies in its expansive product portfolio that serves surgeons and healthcare institutions globally. Their financial engine is powered by the sales of implants and related surgical instruments, meticulously designed to improve surgical outcomes. These products span a wide array of offerings including but not limited to advanced minimally invasive techniques and sophisticated trauma solutions. Beyond the traditional revenue streams, Globus Medical has ventured into promising areas like robotic surgery, thereby augmenting its revenue sources while accessing the benefits of technological advancements. This strategic direction not only strengthens its market position but also ensures it stays at the forefront of providing value-based solutions in the ever-evolving healthcare landscape. By integrating its technological prowess with a deep understanding of clinical needs, Globus Medical continues to carve a robust path for sustainable growth and leadership in the medtech sector.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Globus Medical Inc's most recent financial statements, the company has Operating Margin of 6.8%.
You don't have any saved screeners yet
